跳至主要内容
临床试验/IRCT2015052322381N1
IRCT2015052322381N1已完成3 期

Evaluation of effect of Curcumin on the serum levels of 12-inflammatory cytokines and highly sensitive C-reactive protein level in the patients with Non-alcoholic fatty liver disease (A double-blind, randomized, placebo-controlled trial)

eyshabour University of Medical Sciences0 个研究点目标入组 43 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
43

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 years 至 65 years(—)
性别
All

入选标准

  • Age between 18–65 years
  • The diagnosis of fatty liver using ultrasound

排除标准

  • Women with pregnancy/lactation
  • Alcoholic liver disease
  • Taking anti-inflammatory drugs such as Curtin
  • Acute or chronic liver disorders such as viral (hepatitis B and C) and autoimmune hepatitis
  • Metabolic liver disorders including hemochromatosis and Wilson’s disease, Budd–Chiari syndrome
  • Having other medical disorders such as cardiovascular diseases and cancer
  • Taking liver enzyme enhancement drugs
  • Have severe heart and lung disease
  • Hypothyroidism and hyperthyroidism
  • Alpha-1 antitrypsin deficiency
  • Celiac disease

研究者

发起方
eyshabour University of Medical Sciences

相似试验